Andy J. Minn

29.9k total citations · 10 hit papers
77 papers, 16.0k citations indexed

About

Andy J. Minn is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Andy J. Minn has authored 77 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 41 papers in Molecular Biology and 26 papers in Immunology. Recurrent topics in Andy J. Minn's work include Cancer Immunotherapy and Biomarkers (22 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (10 papers). Andy J. Minn is often cited by papers focused on Cancer Immunotherapy and Biomarkers (22 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (10 papers). Andy J. Minn collaborates with scholars based in United States, Netherlands and Canada. Andy J. Minn's co-authors include Craig B. Thompson, Joan Massagué, William L. Gerald, Lawrence Boise, Paula D. Bos, Weiping Shu, Gaorav P. Gupta, Joseph L. Benci, Dilip D. Giri and Hemant Ishwaran and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Andy J. Minn

75 papers receiving 15.8k citations

Hit Papers

Genes that mediate breast cancer metastasis to lung 1995 2026 2005 2015 2005 2009 1997 2017 1995 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Genes that mediate breast cancer metastasis to lung
    2005 2.2k citations Andy J. Minn, Gaorav P. Gupta et al. profile →
  2. Genes that mediate breast cancer metastasis to the brain
    2009 1.4k citations Paula D. Bos, Don X. Nguyen et al. profile →
  3. Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis
    1997 1.2k citations Andy J. Minn, Craig B. Thompson et al. profile →
  4. Mitotic progression following DNA damage enables pattern recognition within micronuclei
    2017 1.0k citations Joseph L. Benci, Andy J. Minn et al. profile →
  5. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
    1995 1.0k citations Lawrence Boise, Andy J. Minn et al. Immunity profile →
  6. Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
    2016 804 citations Joseph L. Benci, Bihui Xu et al. Cell profile →
  7. Bcl-xL forms an ion channel in synthetic lipid membranes
    1997 682 citations Andy J. Minn, Craig B. Thompson et al. profile →
  8. Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
    2014 660 citations Bihui Xu, Christina Twyman-Saint Victor et al. Cell profile →
  9. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
    2005 522 citations Andy J. Minn, Yibin Kang et al. Journal of Clinical Investigation profile →
  10. Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
    2018 449 citations Andy J. Minn et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy J. Minn United States 46 9.0k 6.3k 4.6k 3.7k 1.6k 77 16.0k
Thomas G. Graeber United States 52 7.6k 0.8× 5.3k 0.8× 3.6k 0.8× 3.8k 1.0× 2.3k 1.5× 141 14.7k
Carsten Müller‐Tidow Germany 64 11.4k 1.3× 4.3k 0.7× 2.2k 0.5× 4.3k 1.2× 1.1k 0.7× 492 18.0k
Øystein Fodstad Norway 68 8.1k 0.9× 5.6k 0.9× 2.6k 0.6× 4.5k 1.2× 2.3k 1.5× 307 14.8k
Iman Osman United States 59 7.5k 0.8× 5.9k 0.9× 2.3k 0.5× 3.0k 0.8× 1.8k 1.1× 265 12.5k
Peter M. Siegel Canada 53 9.0k 1.0× 7.0k 1.1× 1.7k 0.4× 3.6k 1.0× 1.6k 1.0× 148 14.7k
Dihua Yu United States 73 10.9k 1.2× 9.0k 1.4× 2.3k 0.5× 3.9k 1.1× 2.9k 1.8× 242 19.0k
Karin Jirström Sweden 59 5.9k 0.7× 6.2k 1.0× 3.0k 0.6× 3.9k 1.1× 2.1k 1.3× 316 13.3k
Louis M. Weiner United States 65 6.6k 0.7× 8.5k 1.4× 5.3k 1.1× 1.8k 0.5× 2.3k 1.4× 256 16.6k
Holger Kalthoff Germany 62 6.5k 0.7× 6.2k 1.0× 2.6k 0.6× 2.9k 0.8× 1.2k 0.8× 255 12.7k
Andrew L. Kung United States 81 16.6k 1.8× 6.6k 1.0× 2.9k 0.6× 4.6k 1.2× 1.6k 1.0× 285 24.2k

Countries citing papers authored by Andy J. Minn

Since Specialization
Citations

This map shows the geographic impact of Andy J. Minn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy J. Minn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy J. Minn more than expected).

Fields of papers citing papers by Andy J. Minn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy J. Minn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy J. Minn. The network helps show where Andy J. Minn may publish in the future.

Co-authorship network of co-authors of Andy J. Minn

This figure shows the co-authorship network connecting the top 25 collaborators of Andy J. Minn. A scholar is included among the top collaborators of Andy J. Minn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy J. Minn. Andy J. Minn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grayczyk, James P., Luying Liu, Marisa S. Egan, et al.. (2024). TLR priming licenses NAIP inflammasome activation by immunoevasive ligands. Proceedings of the National Academy of Sciences. 121(48). e2412700121–e2412700121. 1 indexed citations
2.
3.
Morral, Clara, Arshad Ayyaz, Hsuan-Cheng Kuo, et al.. (2024). p53 promotes revival stem cells in the regenerating intestine after severe radiation injury. Nature Communications. 15(1). 3018–3018. 22 indexed citations
4.
Ye, Darwin, Elizabeth D. Howell, Erica Bresciani, et al.. (2023). RUNX1 is required in granulocyte–monocyte progenitors to attenuate inflammatory cytokine production by neutrophils. Genes & Development. 37(13-14). 605–620. 14 indexed citations
5.
Cucolo, Lisa, Jingya Qiu, Yongjun Yu, et al.. (2022). The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade. Immunity. 55(4). 671–685.e10. 59 indexed citations
6.
Maity, Amit, Rosemarie Mick, Ramesh Rengan, et al.. (2021). A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes. OncoImmunology. 10(1). 1863631–1863631. 18 indexed citations
7.
Zhou, Zilu, Bihui Xu, Andy J. Minn, & Nancy R. Zhang. (2020). DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing. Genome biology. 21(1). 10–10. 35 indexed citations
8.
Luo, Leo Y., Mark H. O’Hara, Tara C. Mitchell, et al.. (2020). Combining Radiation with Immunotherapy: The University of Pennsylvania Experience. Seminars in Radiation Oncology. 30(2). 173–180. 8 indexed citations
9.
Benci, Joseph L., Lexus R. Johnson, Ruth Choa, et al.. (2019). Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 178(4). 933–948.e14. 304 indexed citations
10.
Rech, Andrew J., Hannah Dada, Jonathan J. Kotzin, et al.. (2018). Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer. Cancer Research. 78(15). 4282–4291. 88 indexed citations
11.
Minn, Andy J. & E. John Wherry. (2016). Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling. Cell. 165(2). 272–275. 208 indexed citations
12.
Minn, Andy J.. (2015). Interferons and the Immunogenic Effects of Cancer Therapy. Trends in Immunology. 36(11). 725–737. 91 indexed citations
13.
Voduc, K. David, Torsten O. Nielsen, Charles M. Perou, et al.. (2015). αB-crystallin expression in breast cancer is associated with brain metastasis. npj Breast Cancer. 1(1). 28 indexed citations
14.
Minn, Andy J., Elena Bevilacqua, Jieun Yun, & Marsha Rich Rosner. (2012). Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle. 11(13). 2452–2457. 23 indexed citations
15.
Martin, Richard W., Brian J. Orelli, Mitsuyoshi Yamazoe, et al.. (2007). RAD51 Up-regulation Bypasses BRCA1 Function and Is a Common Feature of BRCA1 -Deficient Breast Tumors. Cancer Research. 67(20). 9658–9665. 138 indexed citations
16.
Minn, Andy J., Gaorav P. Gupta, David Padua, et al.. (2007). Lung metastasis genes couple breast tumor size and metastatic spread. Proceedings of the National Academy of Sciences. 104(16). 6740–6745. 299 indexed citations
17.
Khodarev, Nikolai N., Andy J. Minn, Elena V. Efimova, et al.. (2007). Ionizing radiation activates interferon-inducible Stat1-dependent pathway and leads to the formation of cross-resistance to irradiation and interferon.. Cancer Research. 67. 2172–2172. 2 indexed citations
18.
Minn, Andy J., Yibin Kang, Inna Serganova, et al.. (2005). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. Journal of Clinical Investigation. 115(1). 44–55. 522 indexed citations breakdown →
19.
Minn, Andy J., et al.. (1998). Recent Progress on the Regulation of Apoptosis by Bcl-2 Family Members. Advances in immunology. 70. 245–279. 57 indexed citations
20.
Minn, Andy J., Lawrence Boise, & Craig B. Thompson. (1996). Bcl-xS Antagonizes the Protective Effects of Bcl-xL. Journal of Biological Chemistry. 271(11). 6306–6312. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas G. Graeber Breakdown of academic impact, for papers by Carsten Müller‐Tidow Breakdown of academic impact, for papers by Øystein Fodstad Breakdown of academic impact, for papers by Iman Osman Breakdown of academic impact, for papers by Peter M. Siegel Breakdown of academic impact, for papers by Dihua Yu Breakdown of academic impact, for papers by Karin Jirström Breakdown of academic impact, for papers by Louis M. Weiner Breakdown of academic impact, for papers by Holger Kalthoff Breakdown of academic impact, for papers by Andrew L. Kung
Rankless by CCL
2026